Seelos Therapeutics Inc (SEELQ)

[SocialBoom]

Yes... I think it's now the right course considering the recent failures with finding a Femprox partner, Abbott, and the US rights.

If they "right sized" the company to a Vitaros only focus they could no doubt cut the expenses in half. I think the one exception is any continued work needed for the Room Temp device.

If sales in Europe are better than expected then they can slowly reintroduce plans for other things while trying to find a buyer, and do so with actual cash generated from Vitaros rather than dilution.

They are like alcoholics with our money.... Sure we can develop RayVa all we have to do is sell several million shares at $1.72

C'mon...